Asia Pacific Tissue Diagnostics Market Size & Outlook

The tissue diagnostics market in Asia Pacific is expected to reach a projected revenue of US$ 2,562.9 million by 2030. A compound annual growth rate of 10% is expected of Asia Pacific tissue diagnostics market from 2024 to 2030.

Revenue, 2023 (US$M)
$1,318.5
Forecast, 2030 (US$M)
$2,562.9
CAGR, 2024 - 2030
10%
Report Coverage
Asia Pacific

Asia Pacific tissue diagnostics market highlights

  • The Asia Pacific tissue diagnostics market generated a revenue of USD 1,318.5 million in 2023.
  • The market is expected to grow at a CAGR of 10% from 2024 to 2030.
  • In terms of segment, immunohistochemistry was the largest revenue generating technology in 2023.
  • Digital Pathology and Workflow is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, South Korea is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 1,318.5 million
Market revenue in 2030USD 2,562.9 million
Growth rate10% (CAGR from 2023 to 2030)
Largest segmentImmunohistochemistry
Fastest growing segmentDigital Pathology and Workflow
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology
Key market players worldwideRoche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 23.8% of the global tissue diagnostics market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,562.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Tissue Diagnostics Market Scope

Tissue diagnostics market segmentation & scope
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Other products
Antibodies
Reagents
Kits
Instruments
Consumables
Software
Primary & Special Staining
Whole Slide Imaging
Image Analysis Informatics
Information Management System Storage & Communication
Microtomes & Cryostat microtomes
Tissue processors
Automatic strainers
Other products
Reagents & Antibodies
Probes & Kits
Others
Breast Cancer
Non Small Cell Lung Cancer
Prostate Cancer
Other Cancers
Gastric Cancer
Hospitals
Research Laboratories
Pharmaceutical Organizations
CRO

Tissue Diagnostics Market Companies

Name Profile # Employees HQ Website

Asia Pacific tissue diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.


Immunohistochemistry was the largest segment with a revenue share of 29.09% in 2023. Horizon Databook has segmented the Asia Pacific tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific market of tissue diagnostics is expected to witness fastest growth over the forecast period. The major factors contributing to this growth are large untapped markets of emerging economies in the region. The market is majorly driven due to rise in cancer incidence across the region.

According to The Cancer Atlas, eastern, southern, and southeastern Asia contributes to 44% of the global cancer cases and 51% of the cancer deaths. China dominates the cancer burden in the region followed by India, Japan, Indonesia, and Republic of Korea.

Top thee applications for cancer tissue diagnostics in the region include breast cancer, lung cancer, and prostate cancer. However, Japan is technologically well versed and the penetration and adoption of benchtop analyzers is higher in Japan, thus attributing to larger share in this market.

Reasons to subscribe to Asia Pacific tissue diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific tissue diagnostics market databook

  • Our clientele includes a mix of tissue diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific tissue diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific tissue diagnostics market size, by country, 2018-2030 (US$M)

Asia Pacific Tissue Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific tissue diagnostics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more